What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Endocrinology
Internal medicine, Endocrinology, Insulin, Pancreatic hormone and Diabetes mellitus are his primary areas of study.
He performs multidisciplinary study on Internal medicine and Crossover study in his works.
His work is connected to Type 2 diabetes, Glucose uptake, Basal, Liraglutide and Carbohydrate metabolism, as a part of Endocrinology.
His work on Insulin resistance, Glucagon, Glucose tolerance test and Glucose clamp technique as part of general Insulin study is frequently connected to Lipid oxidation, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His Pancreatic hormone study combines topics from a wide range of disciplines, such as Blood plasma, Signal transduction, Cell biology and Somatostatin.
His Impaired glucose tolerance study also includes
- Nateglinide and Metabolic syndrome most often made with reference to Hazard ratio,
- Surgery which intersects with area such as Myocardial infarction, Silent Myocardial Infarction, Pioglitazone, Acute coronary syndrome and Macrovascular disease.
His most cited work include:
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. (3386 citations)
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial (716 citations)
- Effect of valsartan on the incidence of diabetes and cardiovascular events. (506 citations)
What are the main themes of his work throughout his whole career to date?
Ole Schmitz mainly investigates Internal medicine, Endocrinology, Insulin, Diabetes mellitus and Insulin resistance.
His Internal medicine study frequently draws connections to adjacent fields such as Type 2 diabetes.
His work deals with themes such as Metformin, Obesity and Type 2 Diabetes Mellitus, which intersect with Type 2 diabetes.
His Insulin research incorporates elements of Somatostatin and Skeletal muscle.
The various areas that he examines in his Diabetes mellitus study include Myocardial infarction and Cardiology.
His biological study spans a wide range of topics, including Adipose tissue, First-degree relatives and VO2 max.
He most often published in these fields:
- Internal medicine (106.38%)
- Endocrinology (100.87%)
- Insulin (68.70%)
What were the highlights of his more recent work (between 2007-2013)?
- Internal medicine (106.38%)
- Endocrinology (100.87%)
- Insulin (68.70%)
In recent papers he was focusing on the following fields of study:
Ole Schmitz mostly deals with Internal medicine, Endocrinology, Insulin, Diabetes mellitus and Insulin resistance.
His work on Internal medicine is being expanded to include thematically relevant topics such as Type 2 diabetes.
His Type 2 diabetes research is multidisciplinary, relying on both Metformin, Obesity, Randomized controlled trial, Reverse cholesterol transport and Hepatic lipase.
In the subject of general Insulin, his work in Glucagon, C-peptide and Pancreatic hormone is often linked to Crossover study, thereby combining diverse domains of study.
His Diabetes mellitus study combines topics in areas such as Cholesterol, Surgery and Myocardial infarction, Cardiology.
In his research, Phenylalanine, Tyrosine and Epinephrine is intimately related to Metabolism, which falls under the overarching field of Insulin resistance.
Between 2007 and 2013, his most popular works were:
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial (716 citations)
- Effect of valsartan on the incidence of diabetes and cardiovascular events. (506 citations)
- Effect of nateglinide on the incidence of diabetes and cardiovascular events (360 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Endocrinology
His primary scientific interests are in Internal medicine, Endocrinology, Type 2 diabetes, Insulin and Diabetes mellitus.
His study in Internal medicine is interdisciplinary in nature, drawing from both Glucagon-like peptide-1 and Surgery.
His Carbohydrate metabolism, Pancreatic islets and Blood pressure study, which is part of a larger body of work in Endocrinology, is frequently linked to Zinc, bridging the gap between disciplines.
His Type 2 diabetes research includes themes of Metformin, Odds ratio, Physiology and Insulin resistance.
His work in the fields of Glycemic overlaps with other areas such as Crossover study.
He has included themes like Hazard ratio and Cardiology in his Diabetes mellitus study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
